Donate Help Contact The AHA Sign In Home
American Heart Association
Hypertension
Search: search_blue_button Advanced Search
Hypertension. 1997;30:337-344

This Article
Right arrow Full Text
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Amiri, F.
Right arrow Articles by Garcia, R.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Amiri, F.
Right arrow Articles by Garcia, R.
Right arrowPubmed/NCBI databases
*Compound via MeSH
*Substance via MeSH
Hazardous Substances DB
*CAPTOPRIL

(Hypertension. 1997;30:337.)
© 1997 American Heart Association, Inc.


Articles

Renal Angiotensin II Receptor Regulation in Two-Kidney, One Clip Hypertensive Rats

Effect of ACE Inhibition

Farhad Amiri; Raul Garcia

From the Laboratory of Experimental Hypertension and Vasoactive Peptides, Clinical Research Institute of Montreal; also affiliated with Université de Montréal (Canada).

Abstract Local renal and plasma renin-angiotensin systems (RAS) both play an important role in blood pressure regulation during the development of two-kidney, one clip Goldblatt hypertension (2K1C) through their vasoactive component, angiotensin II (Ang II). Our goal was to characterize glomerular and preglomerular vascular Ang II receptors during the different stages of development of hypertension in 2K1C rats (2-, 4-, 8-, and 16-weeks postoperative) using Ang II antagonists [Sar1,Ile8]-Ang II, losartan, and PD 123319 and their regulation after angiotensin-converting enzyme (ACE) inhibition by captopril. Competitive binding studies showed that the only Ang II receptor detected on both glomeruli and preglomerular vessels of all groups (2-, 4-, 8-, and 16-week 2K1C rats, control rats, and captopril-treated rats) was the Ang II type 1 receptor (AT1). Vascular AT1 receptor density (Bmax) was significantly lower in only the 16-week 2K1C group, whereas glomerular Bmax was significantly lower in 2K1C rats at 2-, 4-, and 8-weeks. Vascular and glomerular receptor densities were both significantly higher in captopril-treated rats than in nontreated rats. We therefore conclude that in 2K1C rats, Ang II receptors on preglomerular vessels and glomeruli are regulated differentially during the development of hypertension and after ACE inhibition. Our results suggest that glomerular Ang II receptors are regulated by systemic plasma Ang II levels, whereas vascular Ang II receptors are not. However, when renal and systemic RASs are both blocked, these receptors are upregulated but are no longer differentially regulated.


Key Words: angiotensin II • hypertension, renovascular • angiotensin-converting enzyme inhibition • renin-angiotensin system • kidney • rats




This article has been cited by other articles:


Home page
Am. J. Physiol. Regul. Integr. Comp. Physiol.Home page
L. M. Bivol, M. Hultstrom, O. A. Gudbrandsen, R. K. Berge, and B. M. Iversen
Tetradecylthioacetic acid downregulates cyclooxygenase 2 in the renal cortex of two-kidney, one-clip hypertensive rats
Am J Physiol Regulatory Integrative Comp Physiol, December 1, 2008; 295(6): R1866 - R1873.
[Abstract] [Full Text] [PDF]


Home page
HypertensionHome page
J. L. Zhuo
Intrarenal Perfusion and Angiotensin II Levels Regulate In Vivo Angiotensin II Type 1 Receptor Imaging in the Kidney
Hypertension, June 1, 2008; 51(6): e52 - e52.
[Full Text] [PDF]


Home page
HypertensionHome page
J. Xia and Z. Szabo
Response to Intrarenal Perfusion and Angiotensin II Levels Regulate In Vivo Angiotensin II Type 1 Receptor Imaging in the Kidney
Hypertension, June 1, 2008; 51(6): e53 - e53.
[Full Text] [PDF]


Home page
Pharmacol. Rev.Home page
H. Kobori, M. Nangaku, L. G. Navar, and A. Nishiyama
The Intrarenal Renin-Angiotensin System: From Physiology to the Pathobiology of Hypertension and Kidney Disease
Pharmacol. Rev., September 1, 2007; 59(3): 251 - 287.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Renal Physiol.Home page
L. M. Bivol, R. K. Berge, and B. M. Iversen
Differential effect of tetradecythioacetic acid on the renin-angiotensin system and blood pressure in SHR and 2-kidney, 1-clip hypertension
Am J Physiol Renal Physiol, September 1, 2007; 293(3): F839 - F845.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Renal Physiol.Home page
F. Helle, O. B. Vagnes, and B. M. Iversen
Angiotensin II-induced calcium signaling in the afferent arteriole from rats with two-kidney, one-clip hypertension
Am J Physiol Renal Physiol, July 1, 2006; 291(1): F140 - F147.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Renal Physiol.Home page
L. M. Bivol, O. B. Vagnes, and B. M. Iversen
The renal vascular response to ANG II injection is reduced in the nonclipped kidney of two-kidney, one-clip hypertension
Am J Physiol Renal Physiol, August 1, 2005; 289(2): F393 - F400.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Renal Physiol.Home page
F. Amiri and R. Garcia
Renal angiotensin II receptors and protein kinase C in diabetic rats: effects of insulin and ACE inhibition
Am J Physiol Renal Physiol, April 1, 2000; 278(4): F603 - F612.
[Abstract] [Full Text] [PDF]


Home page
J. Am. Soc. Nephrol.Home page
J. WAGNER, F. GEHLEN, A. CIECHANOWICZ, and E. RITZ
Angiotensin II Receptor Type 1 Gene Expression in Human Glomerulonephritis and Diabetes Mellitus
J. Am. Soc. Nephrol., March 1, 1999; 10(3): 545 - 551.
[Abstract] [Full Text]


Home page
HypertensionHome page
L. Cervenka, C.-T. Wang, K. D. Mitchell, and L. G. Navar
Proximal Tubular Angiotensin II Levels and Renal Functional Responses to AT1 Receptor Blockade in Nonclipped Kidneys of Goldblatt Hypertensive Rats
Hypertension, January 1, 1999; 33(1): 102 - 107.
[Abstract] [Full Text] [PDF]


Home page
HypertensionHome page
L. M. Harrison-Bernard, S. S. El-Dahr, D. F. O'Leary, and L. G. Navar
Regulation of Angiotensin II Type 1 Receptor mRNA and Protein in Angiotensin II–Induced Hypertension
Hypertension, January 1, 1999; 33(1): 340 - 346.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Renal Physiol.Home page
L. M. Harrison-Bernard, J. Zhuo, H. Kobori, M. Ohishi, and L. G. Navar
Intrarenal AT1 receptor and ACE binding in ANG II-induced hypertensive rats
Am J Physiol Renal Physiol, January 1, 2002; 282(1): F19 - F25.
[Abstract] [Full Text] [PDF]